DEGS1 and Hepatic steatosis: Decreased hepatic ceramide levels by whole animal or tissue-specific ablation of dihydroceramide desaturase 1 in the liver or adipose tissue ameliorates hepatic steatosis and insulin resistance caused by obesogenic diets51.